| JXSS2400063 | 阿替利珠单抗注射液（皮下注射） | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-07-27 | | | | | view |
| JXSS2400064 | 阿替利珠单抗注射液（皮下注射） | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-07-27 | | | | | view |
| JXSL1900106 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-10-23 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2019-10-22 | view |
| JXSL2100001 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-01-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-01-05 | view |
| JXSL2000043 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2020-05-11 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-05-10 | view |
| JXSS1900004 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-02-25 | | | Certificate Issued | 2020-02-13 | view |
| JYSB2101105 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2021-08-13 | | | | | view |
| JXSB2101001 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.1) | Supplementary Application | 2021-04-01 | | | | | view |
| JYSB2000352 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-07-30 | | | Filed | 2020-08-17 | view |
| JXSL1900100 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-09-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2019-09-27 | view |
| JYSB2400218 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-09-28 | | | | | view |
| JXSL2000205 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-11-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-11-27 | view |
| JXSS2000002 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2020-02-15 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-10-29 | view |
| JXSL2101067 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-07-20 | | | | | view |
| JXSS2101014 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-06-30 | | | | | view |
| JXSL2000088 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | F.Hoffmann-La Roche Ltd | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-07-02 | view |
| JXSB2400102 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-07-25 | | | | | view |
| JXSL2000160 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-24 | | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-09-23 | view |
| JYSB2000674 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | | | Certificate Issued | 2021-03-02 | view |
| JYSB2000139 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-05-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-05-01 | view |
